未找到相关数据
TBCRC 003: Phase II trial of trastuzumab (T) and lapatinib (L) in patients (pts) with HER2+metastatic breast cancer (MBC)
被引：0
作者：
Lin, N. U.
Mayer, I. A.
Najita, J. S.
Hobday, T. J.
Falkson, C. I.
Dees, E. C.
Rimawi, M. F.
Nanda, R.
Gelman, R. S.
Josephs, K.
Richardson, A.
Flores, L.
Van Den Abbeele, A. D.
Yap, J. T.
Arteaga, C. L.
Wolff, A. C.
Krop, I. E.
Winer, E. P.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[3] Mayo Clin, Rochester, MN USA
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Univ Chicago, Chicago, IL 60637 USA
[8] Brigham & Womens Hosp, Boston, MA 02115 USA
[9] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
527
引用
收藏
页数：1
相关论文